Literature DB >> 32573250

Nitrogen-Walk Approach to Explore Bioisosteric Replacements in a Series of Potent A2B Adenosine Receptor Antagonists.

Ana Mallo-Abreu, Rubén Prieto-Díaz, Willem Jespers1, Jhonny Azuaje, Maria Majellaro, Carmen Velando, Xerardo García-Mera, Olga Caamaño, José Brea2, María I Loza2, Hugo Gutiérrez-de-Terán1, Eddy Sotelo.   

Abstract

A systematic exploration of bioisosteric replacements for furan and thiophene cores in a series of potent A2BAR antagonists has been carried out using the nitrogen-walk approach. A collection of 42 novel alkyl 4-substituted-2-methyl-1,4-dihydrobenzo[4,5]imidazo[1,2-a]pyrimidine-3-carboxylates, which contain 18 different pentagonal heterocyclic frameworks at position 4, was synthesized and evaluated. This study enabled the identification of new ligands that combine remarkable affinity (Ki < 30 nM) and exquisite selectivity. The structure-activity relationship (SAR) trends identified were substantiated by a molecular modeling study, based on a receptor-driven docking model and including a systematic free energy perturbation (FEP) study. Preliminary evaluation of the CYP3A4 and CYP2D6 inhibitory activity in optimized ligands evidenced weak and negligible activity, respectively. The stereospecific interaction between hA2BAR and the eutomer of the most attractive novel antagonist (S)-18g (Ki = 3.66 nM) was validated.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32573250     DOI: 10.1021/acs.jmedchem.0c00564

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

1.  A2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models.

Authors:  Apple Hui Min Tay; Rubén Prieto-Díaz; Shiyong Neo; Le Tong; Xinsong Chen; Valentina Carannante; Björn Önfelt; Johan Hartman; Felix Haglund; Maria Majellaro; Jhonny Azuaje; Xerardo Garcia-Mera; Jose M Brea; Maria I Loza; Willem Jespers; Hugo Gutierrez-de-Teran; Eddy Sotelo; Andreas Lundqvist
Journal:  J Immunother Cancer       Date:  2022-05       Impact factor: 12.469

2.  Kinetic profiling and functional characterization of 8-phenylxanthine derivatives as A2B adenosine receptor antagonists.

Authors:  Anna Vlachodimou; Henk de Vries; Milena Pasoli; Miranda Goudswaard; Soon-Ai Kim; Yong-Chul Kim; Mirko Scortichini; Melissa Marshall; Joel Linden; Laura H Heitman; Kenneth A Jacobson; Adriaan P IJzerman
Journal:  Biochem Pharmacol       Date:  2022-04-06       Impact factor: 6.100

3.  Exploring naltrexamine derivatives featuring azaindole moiety via nitrogen-walk approach to investigate their in vitro pharmacological profiles at the mu opioid receptor.

Authors:  Hongguang Ma; Huiqun Wang; James C Gillespie; Rolando E Mendez; Dana E Selley; Yan Zhang
Journal:  Bioorg Med Chem Lett       Date:  2021-03-22       Impact factor: 2.940

Review 4.  Purinergic Signaling: Impact of GPCR Structures on Rational Drug Design.

Authors:  Veronica Salmaso; Kenneth A Jacobson
Journal:  ChemMedChem       Date:  2020-09-18       Impact factor: 3.540

5.  Identification of V6.51L as a selectivity hotspot in stereoselective A2B adenosine receptor antagonist recognition.

Authors:  Xuesong Wang; Willem Jespers; Rubén Prieto-Díaz; Maria Majellaro; Adriaan P IJzerman; Gerard J P van Westen; Eddy Sotelo; Laura H Heitman; Hugo Gutiérrez-de-Terán
Journal:  Sci Rep       Date:  2021-07-08       Impact factor: 4.379

6.  One-Pot Synthesis of Benzo[4,5]imidazo[1,2-a]pyrimidin-2-ones Using a Hybrid Catalyst Supported on Magnetic Nanoparticles in Green Solvents.

Authors:  Alkassoume Moussa; Abbas Rahmati
Journal:  ChemistryOpen       Date:  2021-08       Impact factor: 2.630

7.  Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A1 Antagonists.

Authors:  Cristina Val; Carlos Rodríguez-García; Rubén Prieto-Díaz; Abel Crespo; Jhonny Azuaje; Carlos Carbajales; Maria Majellaro; Alejandro Díaz-Holguín; José M Brea; Maria Isabel Loza; Claudia Gioé-Gallo; Marialessandra Contino; Angela Stefanachi; Xerardo García-Mera; Juan C Estévez; Hugo Gutiérrez-de-Terán; Eddy Sotelo
Journal:  J Med Chem       Date:  2022-01-22       Impact factor: 7.446

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.